Nahee Noh

K-Filler! Advancing to the Global Stage! Let's Go Global! K-Filler's Global Expansion!

  • Written Language: Korean
  • Country: All Countriescountry-flag
  • Beauty

Created: 2024-03-20

Created: 2024-03-20 00:11

K-Filler Going Global

Samyang Holdings targets Indonesia and China.

Hugel, Sizibaio, and Bioplus are expanding beyond Asia to Europe, the Middle East, and South America.


-Domestic filler market size: KRW 140-160 billion

-China's medical beauty market size is expected to reach KRW 61 trillion this year.


Sizibaio

  • Obtained Australian approval for its HA filler 'Eileen'.
  • Has advanced into approximately 31 countries globally.
  • Australia's cosmetic surgery market was approximately KRW 5 trillion in 2022.

Bioplus

  • HA filler 'Dermal Filler'
  • -Completed product registration in Brazil and is scheduled for sales.
  • -Product registration has already been completed in major South American countries such as Argentina, Peru, Colombia, and Ecuador, and the company has entered these markets.


Humedix

  • Developing the Chinese, Brazilian, and South American markets.
  • Subsidiary of Huons Global.


Samyang Holdings

  • High-end filler market (PCL) 'Lapuller'
  • -Contains a polymer substance, resulting in a duration of over two years. It is said to last more than twice as long as hyaluronic acid.
  • -Presented research results demonstrating long-term efficacy and safety in SCI-level international academic journals, gaining recognition for the product's excellence.
  • The only domestic PCL filler supplier, with only two products, Sinclair's 'Ellanse' from the UK, also being available.
  • The polymer filler market accounts for about 10% of the overall filler market. It is a non-reimbursable item. The price is also higher than HA.
  • -Completed product registration in Indonesia in April 2023 and launched in June.
  • -In May 2023, a partnership agreement was signed with Hangzhou Yishinten Technology, a medical device and aesthetics specialist in China.

Written by 2023.12.13


Comments0